Funny thing is none of this is ignored, rather the company and the posters on this forum have acknowledged all these points and addressed them. Yes some academic research is outstanding, is it a big issue? We think not, as it is early days and academic research requires time to resolve. That is how academic research works.. it takes TIME.
People in the industry are aware of this, those who invest in biotechs are aware of this. But for some reason, certain posters want to make it a bigger issue than it is. I'd hazard a guess they've never read a research paper in their life, but suddenly academic research is front page news for them.
Expecting an answer on day dot is either showing how naïve that particular person is, or they are simply being disingenuous. yes this is a long haul, again acknowledged. It's a new ASX company in phase 1 trials... it's no secret there is a long way to go, so I'm not sure why anyone who doesn't like this risk or investment timeframe... it's the reality of this company and the valuation of A$0.1m is reflective of that.
so the issue is how certain posters ask questions and don't accept reasonable researched/educated responses and just insist that they are right because the price went down. Ignoring the fact that there could be many factors at play here, and I assure you there are.. but nope, they are right and we are all wrong. All conversations with them end that way, it always does.
So if someone is wasting our time, I'm going to call it out. Happy to engage in meaningful and respectful discussion, but it has to go both ways.
CHM Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)